These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 34284799)

  • 1. Role of α- and β-adrenergic signaling in phenotypic targeting: significance in benign and malignant urologic disease.
    Archer M; Dogra N; Dovey Z; Ganta T; Jang HS; Khusid JA; Lantz A; Mihalopoulos M; Stockert JA; Zahalka A; Björnebo L; Gaglani S; Noh MR; Kaplan SA; Mehrazin R; Badani KK; Wiklund P; Tsao K; Lundon DJ; Mohamed N; Lucien F; Padanilam B; Gupta M; Tewari AK; Kyprianou N
    Cell Commun Signal; 2021 Jul; 19(1):78. PubMed ID: 34284799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α(1)-Adrenoceptors in the urinary tract.
    Yamada S; Ito Y
    Handb Exp Pharmacol; 2011; (202):283-306. PubMed ID: 21290232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate.
    Michel MC; Vrydag W
    Br J Pharmacol; 2006 Feb; 147 Suppl 2(Suppl 2):S88-119. PubMed ID: 16465187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostatic α1-adrenoceptors: new concepts of function, regulation, and intracellular signaling.
    Hennenberg M; Stief CG; Gratzke C
    Neurourol Urodyn; 2014 Sep; 33(7):1074-85. PubMed ID: 24038148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of isocorynoxeine, from Uncaria, on lower urinary tract dysfunction caused by benign prostatic hyperplasia via antagonism of α
    Li T; Xu K; He J; Jahan N; Song J; Wang S
    Toxicol Appl Pharmacol; 2019 Aug; 376():95-106. PubMed ID: 31145917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of α1a and α1d-adrenoceptors in the prostate by administration of subtype selective α1-adrenoceptor antagonist tamsulosin in patients with benign prostatic hyperplasia.
    Kojima Y; Sasaki S; Kubota Y; Imura M; Oda N; Kiniwa M; Hayashi Y; Kohri K
    J Urol; 2011 Oct; 186(4):1530-6. PubMed ID: 21855934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New strategies for inhibition of non-adrenergic prostate smooth muscle contraction by pharmacologic intervention.
    Yu Q; Gratzke C; Wang Y; Wang X; Li B; Strittmatter F; Herlemann A; Wang R; Tamalunas A; Waidelich R; Stief CG; Hennenberg M
    Prostate; 2019 May; 79(7):746-756. PubMed ID: 30811062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. History and nomenclature of alpha1-adrenoceptors.
    Langer SZ
    Eur Urol; 1999; 36 Suppl 1():2-6. PubMed ID: 10438241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism of α
    Huang R; Tamalunas A; Waidelich R; Strittmatter F; Stief CG; Hennenberg M
    Biochem Pharmacol; 2022 Aug; 202():115148. PubMed ID: 35716783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of human prostate cancer cell growth by alpha1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis.
    Kyprianou N; Benning CM
    Cancer Res; 2000 Aug; 60(16):4550-5. PubMed ID: 10969806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of prostatic smooth muscle contraction by the inhibitor of G protein-coupled receptor kinase 2/3, CMPD101.
    Yu Q; Gratzke C; Wang Y; Herlemann A; Strittmatter F; Rutz B; Stief CG; Hennenberg M
    Eur J Pharmacol; 2018 Jul; 831():9-19. PubMed ID: 29698717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha1 adrenergic receptor blockade in the male lower urinary tract and other body systems.
    Andersson KE
    Scand J Urol Nephrol Suppl; 1995; 168():13-9. PubMed ID: 7541547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The receptor antagonist picotamide inhibits adrenergic and thromboxane-induced contraction of hyperplastic human prostate smooth muscle.
    Hennenberg M; Miljak M; Herrmann D; Strittmatter F; Walther S; Rutz B; Hocaoglu Y; Kunit T; Schreiber A; Andersson KE; Stief CG; Gratzke C
    Am J Physiol Renal Physiol; 2013 Nov; 305(10):F1383-90. PubMed ID: 24049147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α1-adrenoceptor activation induces phosphorylation of β2-adrenoceptors in human prostate tissue.
    Hennenberg M; Strittmatter F; Walther S; Hedlund P; Andersson KE; Stief CG; Schlenker B; Gratzke C
    BJU Int; 2011 Sep; 108(6):922-8. PubMed ID: 21371241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of voiding and storage reflexes by activation of alpha1-adrenoceptors.
    de Groat WC; Yoshiyama M; Ramage AG; Yamamoto T; Somogyi GT
    Eur Urol; 1999; 36 Suppl 1():68-73. PubMed ID: 10393477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotype pharmacology of lower urinary tract α(1)-adrenoceptors.
    Nishimune A; Yoshiki H; Uwada J; Anisuzzaman AS; Umada H; Muramatsu I
    Br J Pharmacol; 2012 Mar; 165(5):1226-34. PubMed ID: 21745191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The concept of uroselectivity.
    Andersson KE
    Eur Urol; 1998; 33 Suppl 2():7-11. PubMed ID: 9556190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell death under epithelial-mesenchymal transition control in prostate cancer therapeutic response.
    Begemann D; Anastos H; Kyprianou N
    Int J Urol; 2018 Apr; 25(4):318-326. PubMed ID: 29345000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of α1-adrenoceptor reduces TGF-β1-induced epithelial-to-mesenchymal transition and attenuates UUO-induced renal fibrosis in mice.
    Ren H; Zuo S; Hou Y; Shang W; Liu N; Yin Z
    FASEB J; 2020 Nov; 34(11):14892-14904. PubMed ID: 32939891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age related changes in the functional, biochemical and molecular properties of alpha1-adrenoceptors in the rat genitourinary tract.
    Yono M; Foster HE; Weiss RM; Latifpour J
    J Urol; 2006 Sep; 176(3):1214-9. PubMed ID: 16890728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.